pravastatin (Athpharma/Biovail)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namepravastatin (Athpharma/Biovail)
Drug Alias NamepravastatinHepacol I
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitors
TargetsHMG-CoA reductase
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaIreland
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAthpharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAthpharma LtdBiovail Corp
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A